Mensinger Mike

Chief Product Officer

Mensinger Mike has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Mensinger Mike is listed as Chief Product Officer at Beta Bionics, Inc. Inside the rolling window, Mensinger Mike reported no open-market purchases and 6 open-market sales totaling $480K in BBNX. The largest disclosed transaction in the window is a sale of 7,800 BBNX shares on Jan 2, 2026, worth $231K.

Companies traded

Other insiders at BBNX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$480K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BBNXSale$84KSep 3SEC ↗
BBNXSale$55KJun 3SEC ↗
BBNXSale$13KMar 3SEC ↗
BBNXSale$66KJan 7SEC ↗
BBNXSale$231KJan 5SEC ↗
BBNXSale$31KDec 4SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Mensinger Mike made?

Mensinger Mike has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.

Which companies does Mensinger Mike trade?

Mensinger Mike has filed SEC Form 4 disclosures for 1 company, including BBNX.

When was Mensinger Mike's most recent SEC Form 4 filing?

Mensinger Mike's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Mensinger Mike's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Mensinger Mike is listed as Chief Product Officer.

What is Mensinger Mike's total buy and sell value in the current window?

Inside the rolling retention window, Mensinger Mike bought $0 and sold $480K based on SEC Form 4 filings.

What was Mensinger Mike's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 7,800 BBNX shares on 2026-01-02, worth $231K, per SEC Form 4 filings.